Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadju…
4 months ago
targetedonc.com
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizumab in HPV16 HNSCC | OncLive
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizu…
Oct 14, 2024
onclive.com
Important updates on locally advanced head and neck squamous cell carcinoma (LA-HNSCC) were presented this year at the #ESMO20 Virtual Congress. In this video, Jean Bourhis reports on key results from the GORTEC 2015-01 “PembroRad” trial testing pembrolizumab vs cetuximab, concomitant with radiotherapy in LA-HNSCC. For more ESMO videos ▶️ http://ow.ly/BeEW50CPkTi #oncology #educationforLIFE | ESMO - European Society for Medical Oncology
3:11
Important updates on locally advanced head and neck squamo…
657 viewsDec 27, 2020
FacebookESMO - European Society for Medical Oncology
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSCC at AACR 2025
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
Dr Siu on the Rationale for Combining Petosemtamab With Pembrolizumab in HNSCC | OncLive
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizumab in Metastatic HNSCC | OncLive
1:59
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
Jul 15, 2024
onclive.com
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
4:01
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation i…
7 months ago
reachmd.com
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
Dr Adkins on the FDA Approval of Pembrolizumab for Neoadjuvant/A…
11 months ago
onclive.com
Dr Uppaluri on the Implications of the FDA Approval of Perioperativ…
10 months ago
onclive.com
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
2:30
Adjuvant Pembrolizumab Delivers Long-Term Benefits in ccRCC at I…
5 months ago
onclive.com
4:26
The Evolving Landscape of Resectable Locally Advanced HNS…
9 months ago
reachmd.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
11 months ago
onclive.com
Lecture Summary - ASCO 2022 NEOPRISM CRC: Neoadjuvant Pe…
37 viewsJun 9, 2022
vumedi.com
KEYNOTE-522: Neoadjuvant and Adjuvant Pembrolizumab in TNB…
Jun 1, 2022
onclive.com
2:14
Patients with stage III or IV melanoma can benefit from adjuva…
2.4K viewsMar 2, 2023
FacebookThe New England Journal of Medicine
4:11
Dr Schmid on the Use of Perioperative Pembrolizumab in T…
Dec 8, 2023
onclive.com
6:31
KEYNOTE-522: Event-Free Survival With Neoadjuvant and Adjuvant P…
Dec 15, 2023
targetedonc.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
4:59
A Comprehensive Guide to Head and Neck Squamous Cell Carcino…
13 views1 month ago
YouTubeComputational GenomeBiology
Dr Haas on 5-Year Outcomes With Adjuvant Pembrolizumab in ccRC…
11 months ago
onclive.com
8:49
Immuncheckpoint-Inhibitoren: Durvalumab beim metastasierten …
174 viewsDec 12, 2019
YouTubeOncoletter
3:12
Opdivo (nivolumab) the Immunotherapy Cancer Treatment
80.6K viewsJun 3, 2016
YouTubeOncology Associates
7:06
Immunotherapy for HNSCC
255 viewsAug 31, 2017
YouTubeOncLive
5:34
Pembrolizumab for Recurrent HNSCC
317 viewsFeb 7, 2017
YouTubeOncLive
23:21
Head & Neck Cancers
341 views7 months ago
YouTubeYale Cancer Center
11:47
Pembrolizumab in HNSCC
654 viewsJul 10, 2017
YouTubeOncLive
5:14
Immunotherapy for Recurrent HNSCC
321 viewsFeb 20, 2017
YouTubeOncLive
3:47
Pembrolizumab as Treatment for Oligometastatic NSCLC
639 viewsDec 5, 2018
YouTubeOncLive
See more videos
Static thumbnail place holder